Filed: 5/18/2026ACC: 0001193125-26-227559
📋 What this filing means
ALLY BRIDGE GROUP (NY) LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $123.81M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$123.81M
Total AUM (reported)
15.90M
Total Shares
Allocation by class
COM$62.97M50.9%
COM NEW$37.01M29.9%
SPONSORED ADS$9.53M7.7%
COM SHS$5.26M4.2%
SHS$4.91M4.0%
ADS$4.14M3.3%
Portfolio Concentration
Top 3$33.94M27.4%
4–10$38.85M31.4%
11–25$49.63M40.1%
Rest$1.39M1.1%
Top 3 weight
27.4%
Top 10 weight
58.8%
Voting Authority Distribution
Total shares with voting rights: 13.80M
Sole
Full voting authority
13.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
SOLENO THERAPEUTICS INC
SOLEShares400K
TypeSH
Market value$13.39M
10.82%
Sole
200K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares32.81K
TypeSH
Market value$10.57M
8.54%
Sole
32.81K
Shared
0.00
None
0.00
MINERVA NEUROSCIENCES INC
SOLEShares1.66M
TypeSH
Market value$9.97M
8.06%
Sole
1.66M
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares2.82M
TypeSH
Market value$6.26M
5.05%
Sole
2.82M
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares1.04M
TypeSH
Market value$5.78M
4.67%
Sole
1.04M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares80.86K
TypeSH
Market value$5.67M
4.58%
Sole
80.86K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares766.97K
TypeSH
Market value$5.52M
4.46%
Sole
766.97K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$5.29M
4.27%
Sole
0.00
Shared
0.00
None
0.00
PROMIS NEUROSCIENCES INC
SOLEShares414.22K
TypeSH
Market value$5.26M
4.25%
Sole
414.22K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares161K
TypeSH
Market value$5.07M
4.10%
Sole
161K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares300K
TypeSH
Market value$4.91M
3.96%
Sole
0.00
Shared
0.00
None
0.00
EUPRAXIA PHARMACEUTICALS INC
SOLEShares660.38K
TypeSH
Market value$4.78M
3.86%
Sole
660.38K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC.
SOLEShares900K
TypeSH
Market value$4.23M
3.42%
Sole
900K
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares745.30K
TypeSH
Market value$4.14M
3.34%
Sole
745.30K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares926.56K
TypeSH
Market value$3.86M
3.12%
Sole
926.56K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares33.71K
TypeSH
Market value$3.75M
3.03%
Sole
33.71K
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares166.96K
TypeSH
Market value$3.68M
2.97%
Sole
166.96K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares202.12K
TypeSH
Market value$3.63M
2.94%
Sole
202.12K
Shared
0.00
None
0.00
CAPRICOR THERAPEUTICS INC
SOLEShares113.90K
TypeSH
Market value$3.46M
2.80%
Sole
113.90K
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$2.98M
2.41%
Sole
0.00
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares817.94K
TypeSH
Market value$2.82M
2.28%
Sole
817.94K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares1.32M
TypeSH
Market value$2.23M
1.80%
Sole
1.32M
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares246.90K
TypeSH
Market value$1.89M
1.53%
Sole
0.00
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares526.32K
TypeSH
Market value$1.80M
1.45%
Sole
526.32K
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares210.53K
TypeSH
Market value$1.47M
1.18%
Sole
210.53K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SOLENO THERAPEUTICS INCSOLE | COM | 400K | SH | $13.39M 10.82% | 200K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 32.81K | SH | $10.57M 8.54% | 32.81K | 0.00 | 0.00 |
MINERVA NEUROSCIENCES INCSOLE | COM NEW | 1.66M | SH | $9.97M 8.06% | 1.66M | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 2.82M | SH | $6.26M 5.05% | 2.82M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 1.04M | SH | $5.78M 4.67% | 1.04M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 80.86K | SH | $5.67M 4.58% | 80.86K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 766.97K | SH | $5.52M 4.46% | 766.97K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 1M | SH | $5.29M 4.27% | 0.00 | 0.00 | 0.00 |
PROMIS NEUROSCIENCES INCSOLE | COM SHS | 414.22K | SH | $5.26M 4.25% | 414.22K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 161K | SH | $5.07M 4.10% | 161K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 300K | SH | $4.91M 3.96% | 0.00 | 0.00 | 0.00 |
EUPRAXIA PHARMACEUTICALS INCSOLE | COM | 660.38K | SH | $4.78M 3.86% | 660.38K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INC.SOLE | COM | 900K | SH | $4.23M 3.42% | 900K | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 745.30K | SH | $4.14M 3.34% | 745.30K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 926.56K | SH | $3.86M 3.12% | 926.56K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 33.71K | SH | $3.75M 3.03% | 33.71K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 166.96K | SH | $3.68M 2.97% | 166.96K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 202.12K | SH | $3.63M 2.94% | 202.12K | 0.00 | 0.00 |
CAPRICOR THERAPEUTICS INCSOLE | COM NEW | 113.90K | SH | $3.46M 2.80% | 113.90K | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 100K | SH | $2.98M 2.41% | 0.00 | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 817.94K | SH | $2.82M 2.28% | 817.94K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 1.32M | SH | $2.23M 1.80% | 1.32M | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 246.90K | SH | $1.89M 1.53% | 0.00 | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 526.32K | SH | $1.80M 1.45% | 526.32K | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 210.53K | SH | $1.47M 1.18% | 210.53K | 0.00 | 0.00 |
Page 1 of 2